Verition Fund Management LLC
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1454027
GREENWICH, CT
Position in ACRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$518,420
+$463,639 QoQ
Shares Held
98,000
+173.7% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 149 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Derivatives in ACRS
reported options exposure · as of Jun 30, 2026CallValue
$105,800
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $156,064,619 across 65 Biotechnology names. ACRS ranks #42 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
438,746 | $30,997,404 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
159,256 | $21,138,048 | |
| 3 | ABVX |
Abivax S.A.
|
105,791 | $14,097,708 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
184,054 | $6,859,692 | |
| 5 | SNDX |
Syndax Pharmaceuticals Inc
|
304,939 | $6,665,966 | |
| 6 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
777,738 | $4,853,085 | |
| 7 | CYTK |
Cytokinetics Inc
|
54,889 | $4,675,993 | |
| 8 | RPRX |
Royalty Pharma plc
|
75,000 | $4,205,250 |
All Filings in ACRS
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,800 | 20,000 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $518,420 | 98,000 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $54,781 | 35,805 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $91,171 | 82,883 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $66,755 | 53,835 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $2,052,842 | 299,685 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,750,112 | 650,927 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,962,826 | 613,452 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,387,696 | 405,568 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,863,260 | 372,507 | Shares | Sole | 2023-01-18 | |
| 2022-06-30 | $4,671,937 | 334,666 | Shares | Sole | 2022-08-30 | |
| 2022-03-31 | $4,404,440 | 255,478 | Shares | Sole | 2022-06-02 | |
| 2021-12-31 | $2,592,627 | 178,310 | Shares | Sole | 2022-05-03 | |
| 2020-12-31 | $639,527 | 98,845 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $105,300 | 65,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||